Globeflex Capital’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-11,192
Closed -$408K 508
2020
Q3
$408K Buy
+11,192
New +$416K 0.11% 286
2016
Q3
Sell
-17,100
Closed -$947K 531
2016
Q2
$947K Hold
17,100
0.26% 148
2016
Q1
$913K Hold
17,100
0.24% 147
2015
Q4
$880K Hold
17,100
0.23% 168
2015
Q3
$772K Sell
17,100
-3,378
-16% -$160K 0.17% 224
2015
Q2
$947K Sell
20,478
-53
-0.3% -$2.32K 0.17% 231
2015
Q1
$881K Sell
20,531
-109
-0.5% -$4.15K 0.17% 242
2014
Q4
$717K Hold
20,640
0.14% 279
2014
Q3
$668K Hold
20,640
0.08% 282
2014
Q2
$699K Buy
+20,640
New +$661K 0.08% 275
2013
Q4
Sell
-34,087
Closed -$1.03M 673
2013
Q3
$1.03M Hold
34,087
0.13% 205
2013
Q2
$993K Buy
+34,087
New +$961K 0.14% 196

Other funds holding PBH

Globeflex Capital's PBH Position: Q4 2020 in Review

Globeflex Capital sold out of Prestige Consumer Healthcare (PBH) in Q4 2020, closing a stake of 11,192 shares — an estimated $408K sold.

Globeflex Capital first reported a position in PBH in Q2 2013 and held it in 12 quarters. The position peaked at $1.03M in Q3 2013. 237 funds tracked by Wall St. Rank hold PBH as of Q4 2020.

  • Globeflex Capital reported no remaining Prestige Consumer Healthcare position as of Q4 2020 after selling out during the quarter.
  • Globeflex Capital sold 11,192 Prestige Consumer Healthcare shares in Q4 2020, an estimated $408K.
  • Globeflex Capital first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 12 quarters.
  • Globeflex Capital's Prestige Consumer Healthcare position peaked at $1.03M in Q3 2013.
  • 237 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2020.

Based on Globeflex Capital's 13F filing for Q4 2020, filed 11 Feb 2021.